July 15 (Reuters) - Longview Acquisition Corp II :
* HEARTFLOW, THE LEADER IN PRECISION HEART CARE, ANNOUNCES MERGER WITH LONGVIEW ACQUISITION CORP. II TO BECOME A PUBLICLY TRADED COMPANY
* LONGVIEW ACQUISITION CORP II - COMBINED PRO FORMA ENTERPRISE VALUE IS APPROXIMATELY $2.4 BILLION
* LONGVIEW ACQUISITION CORP II - TRANSACTION SUPPORTED BY EXISTING INSTITUTIONAL SHAREHOLDERS
* LONGVIEW ACQUISITION CORP II - DEAL WILL ALSO PROVIDE COMBINED COMPANY WITH AN ESTIMATED $400 MILLION IN CASH FOR GROWTH CAPITAL
* LONGVIEW ACQUISITION CORP II - DEAL EXPECTED TO DELIVER UP TO $599 MILLION OF GROSS PROCEEDS TO HEARTFLOW
* LONGVIEW ACQUISITION CORP II - ANY EXCESS CASH IN TRUST TO BE DISTRIBUTED BY CO TO SHAREHOLDERS THROUGH SPECIAL DIVIDEND OF UP TO $91 MILLION PRIOR TO CLOSING
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.